Frank G. Keller

780 total citations
26 papers, 425 citations indexed

About

Frank G. Keller is a scholar working on Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Frank G. Keller has authored 26 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 8 papers in Public Health, Environmental and Occupational Health and 7 papers in Hematology. Recurrent topics in Frank G. Keller's work include Lymphoma Diagnosis and Treatment (9 papers), Acute Lymphoblastic Leukemia research (8 papers) and Childhood Cancer Survivors' Quality of Life (6 papers). Frank G. Keller is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Acute Lymphoblastic Leukemia research (8 papers) and Childhood Cancer Survivors' Quality of Life (6 papers). Frank G. Keller collaborates with scholars based in United States, Canada and France. Frank G. Keller's co-authors include Thomas L. Ortel, William H. Kane, P. Kelly Marcom, B. Gail Macik, H. Newland Oldham, Linda Charles, Mary Ann Quinn-Allen, Jerry A. Peterson, David LaRocca and Qinglin Pei and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Frank G. Keller

24 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank G. Keller United States 10 208 74 66 58 55 26 425
Luz Tarín‐Arzaga Mexico 10 316 1.5× 80 1.1× 69 1.0× 61 1.1× 35 0.6× 34 405
Ernesto de Meis Brazil 12 228 1.1× 48 0.6× 94 1.4× 85 1.5× 23 0.4× 21 484
Sabina Kersting Netherlands 11 269 1.3× 111 1.5× 132 2.0× 51 0.9× 33 0.6× 20 545
Anna Pawłowska United States 11 125 0.6× 65 0.9× 95 1.4× 33 0.6× 63 1.1× 44 465
Byoung Kook Kim South Korea 12 192 0.9× 61 0.8× 135 2.0× 93 1.6× 33 0.6× 43 410
Kyung‐Nam Koh South Korea 14 297 1.4× 91 1.2× 151 2.3× 54 0.9× 92 1.7× 89 660
Emre Tekgündüz Türkiye 10 139 0.7× 42 0.6× 81 1.2× 31 0.5× 32 0.6× 58 316
Yuri Okimoto Japan 10 193 0.9× 43 0.6× 77 1.2× 48 0.8× 37 0.7× 27 440
Alfredo Molteni Italy 13 191 0.9× 104 1.4× 85 1.3× 41 0.7× 36 0.7× 37 480
Philip A. Stevenson United States 14 298 1.4× 87 1.2× 199 3.0× 102 1.8× 71 1.3× 45 733

Countries citing papers authored by Frank G. Keller

Since Specialization
Citations

This map shows the geographic impact of Frank G. Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank G. Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank G. Keller more than expected).

Fields of papers citing papers by Frank G. Keller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank G. Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank G. Keller. The network helps show where Frank G. Keller may publish in the future.

Co-authorship network of co-authors of Frank G. Keller

This figure shows the co-authorship network connecting the top 25 collaborators of Frank G. Keller. A scholar is included among the top collaborators of Frank G. Keller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank G. Keller. Frank G. Keller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Williams, AnnaLynn M., Angie Mae Rodday, Qinglin Pei, et al.. (2024). Longitudinal Health-Related Quality of Life Among Patients With High-Risk Pediatric Hodgkin Lymphoma Treated on the Children's Oncology Group AHOD 1331 Study. Journal of Clinical Oncology. 42(28). 3330–3338. 4 indexed citations
2.
3.
Heneghan, Mallorie B., Susan K. Parsons, Frank G. Keller, et al.. (2024). Protocol-Stipulated Dose Modification to Manage Chemotherapy-Induced Peripheral Neuropathy in Children, Adolescents, and Young Adults With High-Risk Hodgkin Lymphoma. JCO Oncology Practice. 21(4). 526–534. 3 indexed citations
4.
Hoppe, Bradford S., Sharon M. Castellino, Qinglin Pei, et al.. (2023). Radiotherapy Utilization and Outcomes on a Contemporary Trial for Pediatric High-Risk Hodgkin Lymphoma Study. International Journal of Radiation Oncology*Biology*Physics. 117(2). S62–S63. 2 indexed citations
5.
Williams, AnnaLynn M., Angie Mae Rodday, Qinglin Pei, et al.. (2023). Longitudinal Differences By Treatment Arm in Health-Related Quality of Life Among High Risk Pediatric Hodgkin's Lymphoma Patients Treated on the Children's Oncology Group Ahod 1331 Study. Blood. 142(Supplement 1). 672–672. 1 indexed citations
6.
7.
8.
Castellino, Sharon M., Qinglin Pei, Susan K. Parsons, et al.. (2022). Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma. New England Journal of Medicine. 387(18). 1649–1660. 82 indexed citations
9.
Kozono, David, Tyler Zemla, Elie G. Dib, et al.. (2022). 1244 Alliance A151804: Establishment of a national biorepository to advance studies of immune-related adverse events. Regular and Young Investigator Award Abstracts. A1290–A1291. 1 indexed citations
10.
Rossoff, Jenna, Van Huynh, Rachel E. Rau, et al.. (2020). Experience with ponatinib in paediatric patients with leukaemia. British Journal of Haematology. 189(2). 363–368. 20 indexed citations
11.
Parsons, Susan K., et al.. (2018). P056 (0097) COGNITIVE DYSFUNCTION AFTER TREATMENT FOR HODGKIN LYMPHOMA. HemaSphere. 2(S3). 22–22. 3 indexed citations
12.
13.
Keller, Frank G., et al.. (2013). Nodule douloureux de l’oreille : étude descriptive de 99 cas. Annales de Dermatologie et de Vénéréologie. 140(11). 687–692. 6 indexed citations
14.
Jung, Jesse J., et al.. (2009). NEISSERIA SICCA/SUBFLAVA BACTEREMIA PRESENTING AS CUTANEOUS NODULES IN AN IMMUNOCOMPROMISED HOST. The Pediatric Infectious Disease Journal. 28(7). 661–663. 5 indexed citations
15.
Esiashvili, Natia, et al.. (2008). Role of FDG-PET in Definition of Involved-field Radiation Therapy for Pediatric Patients with Hodgkin's Lymphoma. International Journal of Radiation Oncology*Biology*Physics. 72(1). S78–S78.
16.
Wenger, Sharon L., Paul Grossfeld, Benjamin L. Siu, et al.. (2006). Molecular characterization of an 11q interstitial deletion in a patient with the clinical features of Jacobsen syndrome. American Journal of Medical Genetics Part A. 140A(7). 704–708. 22 indexed citations
17.
Luo, Hongyuan, James E. Coad, Paul J. Canfield, et al.. (2005). Dominantly inherited β thalassaemia intermedia caused by a new single nucleotide deletion in exon 2 of the β globin gene: Hb morgantown (β91 CTG>CG). Journal of Clinical Pathology. 58(10). 1110–1112. 11 indexed citations
18.
Keller, Frank G., et al.. (1995). Thrombin-Catalyzed Activation of Recombinant Human Factor V. Biochemistry. 34(12). 4118–4124. 48 indexed citations
19.
Ortel, Thomas L., Linda Charles, Frank G. Keller, et al.. (1994). Topical thrombin and acquired coagulation factor inhibitors: Clinical spectrum and laboratory diagnosis. American Journal of Hematology. 45(2). 128–135. 96 indexed citations
20.
Mannucci, P.M., Armando Tripodi, J. Hirsh, et al.. (1994). Multicentric Evaluation of a New PT Reagent Based on Recombinant Human Tissue Factor and Synthetic Phospholipids. Thrombosis and Haemostasis. 71(3). 292–299. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luz Tarín‐Arzaga Breakdown of academic impact, for papers by Ernesto de Meis Breakdown of academic impact, for papers by Sabina Kersting Breakdown of academic impact, for papers by Anna Pawłowska Breakdown of academic impact, for papers by Byoung Kook Kim Breakdown of academic impact, for papers by Kyung‐Nam Koh Breakdown of academic impact, for papers by Emre Tekgündüz Breakdown of academic impact, for papers by Yuri Okimoto Breakdown of academic impact, for papers by Alfredo Molteni Breakdown of academic impact, for papers by Philip A. Stevenson
Rankless by CCL
2026